Local Inventor Honored for Developing World s First Antihistamine
George Rieveschl, PhD, while a chemical engineering professor at the University of Cincinnati (UC), invented the drug Benadryl, the worlds first effective antihistamine.
Dr. Rieveschl will be recognized in conjunction with the 60th anniversary of Benadryl, commonly used to treat allergy symptoms such as hay fever, rashes and hives. The reception will be held from 5:30 to 7 p.m. at the Queen City Club,
Dr. Rieveschl found that his two-part compound, originally tested to improve muscle-relaxing medications, dramatically blocked histamine, a chemical released in the body that narrows air passages in the lungs and causes inflammation.
This surprising breakthrough led to Benadryl becoming the first FDA-approved prescription antihistamine in 1946. First produced by Parke, Davis and Company, the drug is now distributed over-the-counter by the Parke-Davis division of Pfizer, Inc.
A 1937 alumnus of UC, Dr. Rieveschl spent 26 years working in the chemical industry as both a scientist and a consultant before returning to UC in 1970. He currently is a professor emeritus of environmental engineering.
Jane Henney, MD, senior vice president and provost for health affairs at the UC Academic Health Center, and Karen Gould, PhD, dean of the
Invented by UC scientist George Rieverschl, PhD, Benadryl is the world's first effective antihistamine.
Tags
Related Stories
Clear link discovered between chronic kidney disease and periodontal disease
March 31, 2026
Emerging evidence supports a relationship between chronic kidney disease and oral diseases, according to a recent review from University of Cincinnati College of Medicine researchers published in BMC Nephrology.
UC opens state-of-the-art zebrafish research facility to study infertility
March 31, 2026
The University of Cincinnati College of Medicine has opened a state-of-the-art zebrafish research facility in Cincinnati, Ohio. The Kossack Lab uses zebrafish to study infertility, reproductive health and how environmental contaminants impact human reproductive development.
Exploring GLP-1 drugs for Alzheimer’s prevention
March 30, 2026
University of Cincinnati researchers, funded by the NIH, are studying how GLP-1 drugs may help prevent Alzheimer’s disease by analyzing real-world data from patients with mild cognitive impairment. Learn more about this groundbreaking UC Alzheimer’s research.